Infection par le parvovirus B19: Actualités

Annales de Dermatologie et de Venereologie

Volumn 123, Issue 3, 1996, Pages 208-213

  Karmochkine, M ^a   Chosidow, O ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; PARVOVIRUS; REVIEW; VASCULITIS; VIRUS INFECTION;

ADULT; CHILD; ERYTHEMA INFECTIOSUM; FEMALE; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0029927980     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Naides SJ. Parvovirus B19 infection. Rheum Dis Clin North Am 1993;19:457-75.
2. Anderson LJ. Human parvoviruses. J Infect Dis 1990;161:603-8.
3. Morinet F, Tratschin JD, Pérol Y, Siegl G. Comparison of 17 isolates of the human parvovirus B19 by restriction enzyme analysis. Arch Virol 1986;90:165-72.
4. Leruez M, Pallier C, Vassias I, Elouet JF, Roméo P, Morinet F. Differential transcription without replication of non-structural and structural genes of human parvovirus B19 in UT7-EPO cell line demonstrated by in situ hybridization. J Gen Virol 1994;75:1475-8.
5. Harris JW. Parvovirus B19 for the hematologist. Am J Hematol 1992;39:119-30.
6. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993;262:114-7.
7. Brown KE, Hibbs JR, Gallinella G, Anderson SM, Lehman ED, McCarthy P et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994; 330:1192-6.
8. Lefrère JJ, Mariotti M, Thauvin M. B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates. Lancet 1994;343:211-2.
9. Woolf AD, Campion GV, Chishick A, Wise S, Cohen BJ, Klouda PT et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989;149:1153-6.
10. Bell LM, Naides SJ, Stoffman P, Hodinka RL, Plotkin SA. Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med 1989;321:485-91.
11. De Prost Y. Le parvovirus B19 en pathologie humaine. Ann Dermatol Venereol 1988;115:217-20.
12. Larrègue M, De Larrard G, Bressieux JM. Mégalérythème épidémique ou cinquième maladie. Ann Dermatol Venereol 1986;113:585-9.
13. Khuong MA. Morinet F. Mégalérythème épidémique et autres manifestations liées au parvovirus B19. In: Chosidow O. Virus et peau. Paris : Estem, 1994:101.
14. Schwarz TF, Wiersbitzky S, Pambor M. Detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum. J Med Virol 1994;43:171-4.
15. Labbé L, Mortureux P, Leauté-Labreze C, Taieb A. Parvovirose cutanée : syndrome « gants et chaussettes ». Ann Dermatol Venereol 1994;121:553-6.
16. Reid DM, Reid TMS, Brown T, Rennie JAN, Eastmond CJ. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet 1985;i:422-5.
17. Okumura A, Ichikawa T. Aseptic meningitis caused by human parvovirus B19. Arch Dis Child 1993;68:784-5.
18. Saint-Martin J, Choulot JJ, Bonnaud E, Morinet F. Myocarditis caused by parvovirus. J Pediatr 1990;116:1007-8.
19. Shirono K, Tsuda H. Parvovirus B19-associated haemophagocytic syndrome in helathy adults. Br J Haematol 1995;89:923-6.
20. Tsuda H. Liver dysfunction caused by parvovirus B19. Am J Gastroenterol 1993;88:1463.
21. Naides SJ, Scharoch LL, Foto F, Howard E. Rheumatologic manifestations of human parvovirus B19 infection in adults. Arthritis Rheum 1990;33:1297-309.
22. Aussedat R, Fener P, Pourel J. Coxite aiguë de l'adolescent, manifestation unique d'une infection par le parvovirus B19. Presse Med 1987;16:1978.
23. Chazerain P, Vinciguerra C, Durieux S, Raguin G, Ziza JM. Primo-infection à parvovirus B19 révélée par une lombalgie fébrile isolée. Presse Med 1994;25:446.
24. Ueno Y, Umadome H, Shimodera M, Kishimoto I, Ikegaya K, Yamauchi T. Human parvovirus B19 and arthritis. Lancet 1993; 341:1280.
25. Sasaki T, Takahashi Y, Yoshinaga K, Sugamura K. An association between human parvovirus B19 infection and autoantibody production. J Rheumatol 1989;16:708-9.
26. Sasaki T, Murai C, Muryoi T, Takahashi Y, Munakata Y, Sugamura K et al. Persistent infection of human parvovirus B19 in a normal subjet. Lancet 1995;346:851.
27. Nikkari S, Luukkainen R, Möttönen T, Meurman O, Hannonen P, Skurnik M et al. Does parvovirus B19 have a role in rheumatoid arthritis? Ann Rheum Dis 1994;53:106-11.
28. Bagot M, Revuz J. Papular-purpuric « gloves and socks » syndrome: primary infection with parvovirus B19. J Am Acad Dermatol 1991;25:341-2.
29. Bessis D, Lamaury I, Jonquet O, Segondy M, Janbon F. Human parvovirus B19 induced papular-purpuric « gloves and socks » syndrome. Eur J Dermatol 1994;4:133-4.
30. Dinerman JL, Corman LC. Human parvovirus B19 arthropathy associated with desquamation. Am J Med 1990;89:826-8.
31. Lefrère JJ, Courouce AM, Muller JY, Clerk M, Soulier JP. Human parvovirus and purpura. Lancet 1985;ii:730.
32. Lobkowicz F, Ring J, Schwarz TF, Rozendorf M. Erythema multiforme in a patient with acute human parvovirus infection. J Am Acad Dermatol 1989;20:849-50.
33. Imbert B, Brion JP, Janbon J, Gonzales M, Micoud M. Érythème noueux associé à une infection à parvovirus B19. Presse Med 1989;18:1753-4.
34. Dereure O, Montes B, Guilhou JJ. Acute generalized livedo reticularis with myasthenia-like syndrome revealing parvovirus B19 primary infection. Arch Dermatol 1995;131:744-5.
35. Anderson MJ, Higgings PG, Davis LR, Willman JS, Jones SE, Kidd IM et al. Experimental parvoviral infection in humans. J Infect Dis 1985;152:257-65.
36. Potter CG, Potter AC, Hatton SCR, Chapel HM, Anderson MJ, Pattison JR et al. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest 1987;79: 1486-92.
37. Serjeant GR, Serjeant BE, Thomas PW, Anderson MJ, Patou G, Pattison JR. Human parvovirus infection in homozygous sickle cell disease. Lancet 1993;341:1237-40.
38. Finkel TH, Török TJ, Ferguson PJ, Durigon EL, Zaki SR, Leung DYM et al. Chronic parvovirus B19 infection and systemic necrositing vasculitis: opportunistic infection or aetiological agent? Lancet 1994;343:1255-8.
39. Leruez-Ville M, Laugé A, Morinet F, Guillevin L, Dény P. Polyarteritis nodosa and parvovirus B19. Lancet 1994;344:263-4.
40. Godeau B, Palazzo E, Morinet F, Deplanche M, Deforge L, Schaeffer A et al. Is Still's disease associated with parvovirus B19 infection? Lancet 1994;345:59-60.
41. Nigro G, Zerbini M, Krzysztofiak A, Gentilomi G, Porcaro MA, Tango T et al. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet 1994;343:1260-1.
42. Hamon MD, Newland AC, Anderson MJ. Severe aplastic anemia after parvovirus infection in the absence of underlying haemolytic anaemia. J Clin Pathol 1988;41:1242.
43. McClain K, Estrov Z, Chen H, Mahoney DH. Chronic neutropenia of childhood: frequent association with parvovirus infection and correlations with bone marrow culture studies. Br J Haematol 1993;85:57-62.
44. Ilaria RL, Komaroff AL, Fagioli LR, Moloney WC, True CA, Naides SJ. Absence of parvovirus B19 infection in chronic fatigue syndrome. Arthritis Rheum 1995;5:638-41.
45. Hall CJ. Parvovirus B19 in pregnancy. Arch Dis Child 1994; 71:4-5.
46. Gratacos E, Torres PJ, Vidal J, Antolin E, Costa J, Jimenez de Anta MT et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995;171:1360-3.
47. Guidozzi F, Ballot D, Rothberg AD. Human B19 parvovirus infection in an obstetric population. A prospective study determining fetal outcome. J Reprod Med 1994;39:36-8.
48. Peters MT, Nicolaides KH. Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection. Obstet Gynecol 1990;75:501-4.
49. Kurtzman GJ, Ozawa K, Cohen B, Hanson G. Oseas R, Young NS. Chronic bone marrow failure due to persistent B19 parvovirus B19 infection. N Engl J Med 1987;317:287-94.
50. Frickhofen N, Chen ZJ, Young NS, Cohen BJ, Heimpel H, Abkowitz JL. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia. Br J Haematol 1994;87:818-24.
51. Karmochkine M, Oksenhendler E, Leruez-Ville M, Jaccard A, Monnet F, Herson S. Persistent parvovirus B19 infection and pure red cell aplasia in Waldenström's macroglobulinemia: successfull treatment with high dose intravenous immunoglobulin. Am J Hematol 1995;50:227-8.
52. Nour B, Green M, Michaels M, Reyes J, Tzakis A, Gartner JC et al. Parvovirus B19 infection in pediatric transplant patients. Transplantation 1993;56:835-8.
53. Frickhofen N, Abkowitz JL, Safford M, Berry JM, Autunezde-Mayolo J, Astrow A et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990;113:926-33.
54. Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989;84:1114-23.
55. Kurtzman GJ, Frickhofen N, Kimball J, Jenkis DW, Nienhuis AW, Yoing NS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989;321:519-23.
56. Chernak E, Dubin G, Henry D, Naides SJ, Hodinka RL, McGregor RR et al. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis 1995;20:170-3.
57. Clewley JP. Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol 1989;27:2647-51.
58. Sahakian V, Weiner CP, Naides SJ. Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Am J Obstet Gynecol 1991;164:1090-1.
59. Smoleniec JS, Pillai M. Management of fetal hydrops associated with parvovirus B19 infection. Br J Obstet Gynecol 1994; 101:1079-81.
60. Selbing A, Josefsson A, Dahle LO, Lindgren R. Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin. Lancet 1995;345:660-1.
61. Schwarz TE, Roggendorf M, Hottenträger B, Modrow S, Deinhardt F, Middeldorp J. Immunoglobulins in the prophylaxis of parvovirus B19 injection. J Infect Dis 1990;162:1214.